BACKGROUND: Drug users (DUs) are at high risk of viral hepatitis A, B, and C (HAV, HBV, HCV).
METHODS: We examined the prevalence of HAV, HBV, and HCV, associated factors, and vaccine seroconversion among drug treatment program participants in a randomized controlled trial of hepatitis care coordination.
RESULTS: Of 489 participants, 44% and 47% required HAV/HBV vaccination, respectively; 59% were HCV positive requiring linkage to care. Factors associated with serologic statuses, and vaccine seroconversion are reported; implications for strategies in drug treatment settings are discussed. CONCLUSIONS:
Results suggest generalizable strategies for drug treatment programs to expand viral hepatitis screening, prevention, vaccination and linkage to care.
Viral hepatitis among drug users in methadone maintenance: Associated factors, vaccination outcomes, and interventions
Journal of Addictive Diseases, 33 (4), 322-331. doi: 10.1080/10550887.2014.969623. PMCID: PMC4275379.